Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07390591

Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms

The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is:

1. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI

Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations.

Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Participants in this study will engage in an in-depth qualitative semi-structured interview process designed to explore their experiences with intravesical instillation practices. Each participant will complete a one-hour interview, during which they will be asked about their personal routines, decision-making factors, and perceptions related to bladder instillations. To ensure accuracy of interpretation, participants may also be invited to take part in brief follow-up discussions lasting no more than 30 minutes each. These follow-up interactions will occur within 12 months of the initial interview, and the total participation time will not exceed 2.5 hours over the study period.

All interviews will be audio-recorded, transcribed, reviewed for accuracy, and analyzed using a secure, cloud-based qualitative data analysis platform that allows linked review of audio and transcript files. Interviews will continue until data saturation is reached, meaning no new concepts emerge from additional participants.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Criteria for patients:

  • Age 18+
  • Diagnosis of NLUTD
  • Chronic catheter usage (minimum 6 months), either intermittent catheterization or indwelling catheter
  • Community-dwelling
  • Experience using intravesical Lactobacillus, gentamicin, or combination of the two

Criteria for caregivers:

  • Age 18+
  • Care for patient with diagnosis of NLUTD
  • Care for patient who has used catheters chronically (minimum 6 months)
  • Experience facilitating patients' use of intravesical Lactobacillus, gentamicin, or combination of the two

Exclusion criteria

  • Psychiatric or psychologic conditions impacting ability to consent

Treatment and study plan

Primary outcomes

  1. Advancing intravesical instillation for urinary health

    Time frame: 12 months

    Qualitative interviews will be coded, and themes how to advance intravesical instillation for urinary health will emerge.

Study contacts

Contact information is provided by the study sponsor or research team.

Christopher Riegner, MPH

CONTACT

[email protected]

202-892-5857

Inger Ljungberg, MPH

CONTACT

[email protected]

202-877-1694

Sponsors and collaborators

Lead sponsor

Medstar Health Research Institute

Other

Collaborators

  • Congressionally Directed Medical Research Programs

Registry information

Official study title

Intravesical Gentamicin Coupled With Lactobacillus Rhamnosus for Urinary Health- Early Career

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Feb 5, 2026
Registry last updated
Feb 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.